Stock Events

Beroni Limited 

$0.82
1
+$0+0% Thursday 20:00

Statistics

Day High
0.82
Day Low
0.82
52W High
9.88
52W Low
0.25
Volume
2,000
Avg. Volume
100
Mkt Cap
18.9M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30JunConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q4 2020
Q1 2021
-0.02
-0.01
-0.01
0
Expected EPS
0
Actual EPS
-0.0072

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNIGF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies for infectious diseases, a key area of focus for Beroni as well.
Regeneron Pharmaceuticals
REGN
Mkt Cap114.81B
Regeneron Pharmaceuticals is involved in biopharmaceutical research, particularly in infectious diseases, competing directly with Beroni's research initiatives.
Vertex Pharmaceuticals
VRTX
Mkt Cap126.85B
Vertex Pharmaceuticals focuses on creating new treatments for viral diseases and other chronic conditions, overlapping with Beroni's target markets.
AMGEN
AMGN
Mkt Cap177.72B
Amgen is a global biotech leader that develops innovative therapeutics in areas similar to Beroni, including infectious diseases.
Moderna
MRNA
Mkt Cap46.43B
Moderna is known for its mRNA technology used in vaccines, competing in the biotechnological innovation space where Beroni is also active.
BioNTech
BNTX
Mkt Cap20.32B
BioNTech SE works on novel therapies in the biotechnology field, directly competing with Beroni's efforts in biopharmaceuticals.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a large pharmaceutical company with a broad product line that includes treatments for infectious diseases, competing with Beroni's products.
Novartis
NVS
Mkt Cap232.42B
Novartis is a global healthcare company that produces drugs in many of the same categories as Beroni, including viral and other infectious diseases.
Astrazeneca
AZN
Mkt Cap244.04B
AstraZeneca operates in the biopharmaceutical sector focusing on various therapeutic areas, including those targeted by Beroni.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson engages in the research and development of pharmaceuticals for infectious diseases, similar to Beroni's focus areas.

About

Biotechnology
Health Technology
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, and health care products and supplements in China, Australia, the United States, and Japan. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic products, and Viral Diagnostic Kits segments. The company's products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system. It also offers cosmetic products, such as V show rejuvenation liquids, hyaluronic acid moisturizing silk masks, and avocado poly-peptide intensive treatment silk masks. In addition, the company provides SARS-CoV-2 IgG/IgM antibody detection kit, as well as sells CII-ArboViroPlex rRT-PCR assay, a diagnostic kit used to detect viruses such as Zika, Dengue, Chikungunya, and West Nile. Further, it engages in the research and development of new drugs and clinical trial; gene detection and diagnosis, as well as sale of cell therapies for cancer and anti-aging treatments; developing new anti-cancer drugs; detection and diagnosis of infectious diseases; and e-commerce platform for pharmaceutical and healthcare products. Additionally, the company sells stem cell cosmetic products. The company was founded in 2014 and is headquartered in Sydney, Australia.
Show more...
CEO
Country
AU
ISIN
AU000000BTG8
WKN
000A2JA0M

Listings